增殖细胞核抗原
Ki-67
免疫组织化学
增殖标记
肺癌
病理
单克隆抗体
抗原
细胞生长
生物
抗体
医学
癌症研究
免疫学
遗传学
作者
Roxana Folescu,Codrina Mihaela Levai,Mirela Loredana Grigoraş,Teodora Smaranda Arghirescu,Ioana Cristina Talpoş,Ciprian Gindac,C Zamfir,Vladimir Poroch,Mirella Dorina Anghel
出处
期刊:PubMed
日期:2018-01-01
卷期号:59 (1): 227-233
被引量:23
摘要
Ki-67 parameter is a proliferation marker in malignant tumors. The increased proliferation activity and the decreased prognosis in lung cancer determined us to investigate different parameters connected to the tumor's aggression, such as cellularity, Ki-67 positivity rate, and proliferating cell nuclear antigen (PCNA). We evaluated the proliferative activity in 62 primary lung tumors by determining the cell's percentage of Ki-67 and immunoreactive PCNA (using MIB-1 and PCNA monoclonal antibodies), classifying Ki-67 and PCNA immunoreactivity into three score groups. The results obtained emphasized a linkage between Ki-67 score with the histological tumor subtype, tumor cellularity and degree of differentiation and with other proliferation immunohistochemistry (IHC) markers, such as p53 cellular tumor antigen. The tumor's cellularity, the Ki-67 positivity rate and PCNA, together with the clinical stage and the histological differentiation bring extra pieces of useful information in order to anticipate the evolution and the prognosis of lung cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI